Change of Director's Interest Notice
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Appendix 3Y
Rule 3.19A.2
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
Mayne Pharma Group Limited
ABN
76 115 832 963
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director
Bruce Robinson
Date of last notice
11 January 2017
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
Netwealth Investments Limited <Wrap
Services A/C>, via BRAK Super Pty Ltd
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change
28 February 2022
No. of securities held prior to change
31,744
Class
Ordinary Shares
Number acquired
Nil
Number disposed
15,102
Value/Consideration
N/A
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
16,642
Appendix 3Y
Change of Director’s Interest Notice
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Transferred in accordance with domestic
arrangements / settlement.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
Not applicable
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade Not applicable
to proceed during this period?
If prior written clearance was provided, on what date was this Not applicable
provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Share your feedback
Discover